38766828|t|Effects of Cycloastragenol on Alzheimer's Disease in Rats by Reducing Oxidative Stress, Inflammation, and Apoptosis.
38766828|a|BACKGROUND: As individuals age, they may develop Alzheimer's disease (AD), which is characterized by difficulties in speech, memory loss, and other issues related to neural function. Cycloastragenol is an active ingredient of Astragalus trojanus and has been used to treat inflammation, aging, heart disease, and cancer. OBJECTIVES: This study aimed to explore the potential therapeutic benefits of cycloastragenol in rats with experimentally induced AD. Moreover, the underlying molecular mechanisms were also evaluated by measuring Nrf2 and HO-1, which are involved in oxidative stress, NFkappaB and TNF-alpha, which are involved in inflammation, and BCL2, BAX, and caspase-3, which are involved in apoptosis. METHODS: Sprague-Dawley rats were given 70 mg/kg of aluminum chloride intraperitoneally daily for six weeks to induce AD. Following AD induction, the rats were given 25 mg/kg of cycloastragenol daily by oral gavage for three weeks. Hippocampal sections were stained with hematoxylin/ eosin and with anti-caspase-3 antibodies. The Nrf2, HO-1, NFkappaB, TNF-alpha, BCL2, BAX, and caspase-3 gene expressions and protein levels in the samples were analyzed. RESULTS: Cycloastragenol significantly improved rats' behavioral test performance. It also strengthened the organization of the hippocampus. Cycloastragenol significantly improved behavioral performance and improved hippocampal structure in rats. It caused a marked decrease in the expression of NFkappaB, TNF-alpha, BAX, and caspase-3, which was associated with an increase in the expression of BCL2, Nrf2, and HO-1. CONCLUSION: Cycloastragenol improved the structure of the hippocampus in rats with AD. It enhanced the outcomes of behavioral tests, decreased the concentration of AChE in the brain, and exerted antioxidant and anti-inflammatory effects. Antiapoptotic effects were also noted, leading to significant improvements in cognitive function, memory, and behavior in treated rats.
38766828	11	26	Cycloastragenol	Chemical	MESH:C061014
38766828	30	49	Alzheimer's Disease	Disease	MESH:D000544
38766828	53	57	Rats	Species	10116
38766828	88	100	Inflammation	Disease	MESH:D007249
38766828	166	185	Alzheimer's disease	Disease	MESH:D000544
38766828	187	189	AD	Disease	MESH:D000544
38766828	242	253	memory loss	Disease	MESH:D008569
38766828	300	315	Cycloastragenol	Chemical	MESH:C061014
38766828	390	402	inflammation	Disease	MESH:D007249
38766828	411	424	heart disease	Disease	MESH:D006331
38766828	430	436	cancer	Disease	MESH:D009369
38766828	516	531	cycloastragenol	Chemical	MESH:C061014
38766828	535	539	rats	Species	10116
38766828	568	570	AD	Disease	MESH:D000544
38766828	651	655	Nrf2	Gene	83619
38766828	660	664	HO-1	Gene	24451
38766828	719	728	TNF-alpha	Gene	24835
38766828	752	764	inflammation	Disease	MESH:D007249
38766828	770	774	BCL2	Gene	24224
38766828	776	779	BAX	Gene	24887
38766828	785	794	caspase-3	Gene	25402
38766828	853	857	rats	Species	10116
38766828	881	898	aluminum chloride	Chemical	MESH:D000077410
38766828	947	949	AD	Disease	MESH:D000544
38766828	961	963	AD	Disease	MESH:D000544
38766828	979	983	rats	Species	10116
38766828	1007	1022	cycloastragenol	Chemical	MESH:C061014
38766828	1100	1111	hematoxylin	Chemical	MESH:D006416
38766828	1113	1118	eosin	Chemical	MESH:D004801
38766828	1133	1142	caspase-3	Gene	25402
38766828	1159	1163	Nrf2	Gene	83619
38766828	1165	1169	HO-1	Gene	24451
38766828	1181	1190	TNF-alpha	Gene	24835
38766828	1192	1196	BCL2	Gene	24224
38766828	1198	1201	BAX	Gene	24887
38766828	1207	1216	caspase-3	Gene	25402
38766828	1292	1307	Cycloastragenol	Chemical	MESH:C061014
38766828	1331	1335	rats	Species	10116
38766828	1424	1439	Cycloastragenol	Chemical	MESH:C061014
38766828	1524	1528	rats	Species	10116
38766828	1589	1598	TNF-alpha	Gene	24835
38766828	1600	1603	BAX	Gene	24887
38766828	1609	1618	caspase-3	Gene	25402
38766828	1679	1683	BCL2	Gene	24224
38766828	1685	1689	Nrf2	Gene	83619
38766828	1695	1699	HO-1	Gene	24451
38766828	1713	1728	Cycloastragenol	Chemical	MESH:C061014
38766828	1774	1778	rats	Species	10116
38766828	1784	1786	AD	Disease	MESH:D000544
38766828	1865	1869	AChE	Gene	83817
38766828	1917	1929	inflammatory	Disease	MESH:D007249
38766828	2069	2073	rats	Species	10116
38766828	Positive_Correlation	24835	83619
38766828	Association	24451	25402
38766828	Positive_Correlation	24451	24887
38766828	Positive_Correlation	24887	83619
38766828	Negative_Correlation	MESH:C061014	MESH:D000544
38766828	Positive_Correlation	MESH:C061014	83619
38766828	Association	24451	24835
38766828	Positive_Correlation	MESH:C061014	24224
38766828	Negative_Correlation	MESH:C061014	25402
38766828	Association	MESH:D007249	24835
38766828	Negative_Correlation	MESH:C061014	MESH:D006331
38766828	Negative_Correlation	MESH:C061014	24887
38766828	Association	25402	83619
38766828	Negative_Correlation	MESH:C061014	83817
38766828	Negative_Correlation	MESH:C061014	24835
38766828	Negative_Correlation	MESH:C061014	MESH:D009369
38766828	Negative_Correlation	MESH:C061014	MESH:D007249
38766828	Association	MESH:C061014	24451
38766828	Positive_Correlation	MESH:D000077410	MESH:D000544

